L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin (Q33398403)

26 July 2017

title

L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin (English)

1 reference

26 July 2017

1 reference

5

1 reference

26 July 2017

10

1 reference

26 July 2017

Sergio Neri

7

0 references

Mariano Malaguarnera

object named as

Mariano Malaguarnera

8

0 references

author name string

Michele Malaguarnera

1

1 reference

26 July 2017

Marco Vacante

2

1 reference

26 July 2017

Maria Giordano

3

1 reference

26 July 2017

Massimo Motta

4

1 reference

26 July 2017

Manuela Pennisi

6

1 reference

26 July 2017

Giovanni Li Volti

9

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 October 2011

1 reference

World Journal of Gastroenterology

26 July 2017

published in

1 reference

26 July 2017

volume

17

1 reference

26 July 2017

issue

39

1 reference

26 July 2017

page(s)

4414-4420

1 reference

Impact of interferon-alpha treatment on liver fibrosis in patients with chronic hepatitis B: an overview of published trials

26 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

L-Carnitine halts apoptosis and myelosuppression induced by carboplatin in rat bone marrow cell cultures (BMC).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

Side effects of therapy of hepatitis C and their management

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

Interferon-mediated fatigue

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

Neuropsychiatric effects and type of IFN-alpha in chronic hepatitis C.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

Efficacy of different schedules in the management of chronic hepatitis C with interferon-alpha.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

Interferon-alpha therapy for refractory idiopathic thrombocytopenic purpura in children.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

Second-generation line probe assay for hepatitis C virus genotyping

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

Effects of long-chain acyl carnitine on membrane fluidity of human erythrocytes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

Immunological parameters in aging: studies on natural immunomodulatory and immunoprotective substances

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

L-carnitine modulates blood platelet oxidative stress

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

Sexual dysfunction in chronic hepatitis C virus patients treated with interferon alpha and ribavirin

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

Role of L-carnitine in the modulation of immune response in aged rats

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

Protective effect of intravenous levocarnitine on subsequent-month hospitalization among prevalent hemodialysis patients, 1998 to 2003.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

L-carnitine treatment reduces steatosis in patients with chronic hepatitis C treated with alpha-interferon and ribavirin.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

Effect of L-carnitine on the physical fitness of thalassemic patients.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

L-Carnitine ameliorates methotrexate-induced oxidative organ injury and inhibits leukocyte death.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

Effect of L-carnitine on acetyl-CoA content and activity of blood platelets in healthy and diabetic persons.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

Peritoneal macrophages function modulation by L-carnitine in aging rats

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

Efficacy of human recombinant erythropoietin plus IFN-alpha in patients affected by chronic hepatitis C.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

Serum levels of lipids and lipoproteins in Syrian patients with beta-thalassemia major.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

Carnitine: a neuromodulator in aged rats

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

L-carnitine decreases severity and type of fatigue induced by interferon-alpha in the treatment of patients with hepatitis C.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

Carnitine inhibits arachidonic acid turnover, platelet function, and oxidative stress

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

The influence of l-carnitine supplementation on hematocrit and hemoglobin levels in patients with end stage renal failure on CAPD.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

Premature discontinuation of interferon plus ribavirin for adverse effects: a multicentre survey in 'real world' patients with chronic hepatitis C.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

Effects of L-carnitine supplementation on renal anemia in poor responders to erythropoietin.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

Interferon alpha-2B and ribavirin in combination for patients with chronic hepatitis C who failed to respond to, or relapsed after, interferon alpha therapy: a randomized trial.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

A proposed system for the nomenclature of hepatitis C viral genotypes

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218156

Recommendations guiding physicians in biomedical research involving human subjects. World Medical Association Declaration of Helsinki

31 October 2018

1 reference

12 December 2020

Lipid peroxidation and antioxidant status in beta-thalassemia

1 reference

12 December 2020

The role of poly(ADP-ribose) polymerase (PARP) in the autonomous proliferative response of endothelial cells to hypoxia

1 reference

12 December 2020

Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients

1 reference

12 December 2020

Muscle carnitine deficiency and lipid storage myopathy in patients with mitochondrial myopathy

1 reference

12 December 2020

Inhibition of platelet-activating factor synthesis in human neutrophils and platelets by propionyl-L-carnitine

1 reference

12 December 2020

Interferon Alpha-Induced Depression in Chronic Hepatitis C Patients: Comparison between Different Types of Interferon Alpha

1 reference

12 December 2020

Correlation between serum carnitine levels and erythrocyte osmotic fragility in hemodialysis patients

1 reference

12 December 2020

Protection of beta-thalassaemic erythrocytes from oxidative stress by propionyl carnitine

1 reference

12 December 2020

L-carnitine inhibits a subset of platelet activation responses in chronic uraemia

1 reference

12 December 2020

Serum Carnitine Levels in Chronic Hepatitis C Patients Before and After Lymphoblastoid Interferon-?? Treatment

1 reference

12 December 2020

Alpha-interferon (IFN-alpha) treatment of chronic hepatitis C: analysis of some predictive factors for the response

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V17.I39.4414

1 reference

26 July 2017

1 reference

26 July 2017

1 reference